Dobucare 12.5mg Injection
By Dobucare
Rx
20ml Injection in a Vial

Composition
Dobutamine(12.5mg)

Manufacturer - Criticare Laboratories Pvt Ltd
163/2, Reservoir Street, Basavanagudi, Bangalore-560004.

Expires on or after
October, 2025

liver
Consult your healthcare provider for appropriate guidance when considering the use of Dobucare 12.5mg Injection in individuals with liver conditions, as there is limited data regarding its safety profile in such cases. It is essential to seek medical advice to ensure the medication's suitability and any potential risks involved.

kidney
Limited data indicates Dobucare 12.5mg Injection is likely safe for kidney disease patients and may not require dose adjustment. Consult your doctor for more guidance.

alcohol
It is unclear if it is safe to consume alcohol while using Dobucare 12.5mg Injection. Consult your doctor for advice regarding alcohol consumption with this medication.

driving
Dobucare 12.5mg Injection can have side effects that may impact your driving skills.

pregnancy
Dobucare 12.5mg Injection is generally safe to use during pregnancy. Animal studies suggest minimal harm to the baby, but human data is limited.

breastfeeding
Dobucare 12.5mg Injection is likely safe for breastfeeding mothers based on limited data, indicating minimal risks to the baby.
Habit Forming | No |
Chemical Class | Catecholamine Derivative |
Therapeutic Class | - |
Action Class | Sympathomimetics agonist-Inotropes |
₹296.97
Inclusive of all taxes
Content verified by

Dr. Preeti Kumar
MBBS, DGO - Obstetrics and Gynaecology, DNB - Obstetrics and Gynaecology
Last update on 11-Feb-2025